Literature DB >> 3420617

The effect of dietary protein levels on xenobiotic biotransformations in F344 male rats.

L E Butler1, W C Dauterman.   

Abstract

Diets containing protein levels of 8, 12, and 22% were fed for 14 days to Fischer 344 male weanling rats. Enzyme activities in liver and kidney were measured using several substrates for each of the following enzyme systems: Cytochrome P-450-dependent monooxygenase, ester hydrolysis, and conjugations with sulfate, glutathione, and glucuronic acid. Enzyme activities, for the various mechanisms, decreased from 15 to 65% with decreased dietary protein, with the exception of glucuronide and sulfate conjugation, which increased with decreased dietary protein. In vivo effects were evaluated by measuring hexobarbital sleeping time, procaine paralysis time, and bromobenzene hepatotoxicity. Increased dietary protein shortened hexobarbital sleeping time and procaine paralysis time, and increased procaine lethality, whereas low protein intake protected against bromobenzene hepatotoxicity. These data suggest that typical laboratory diets (22-25% protein) may provide artificially altered activities of xenobiotic biotransformation in rats, relative to nutritionally adequate (12% protein) diets.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3420617     DOI: 10.1016/0041-008x(88)90166-4

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  2 in total

Review 1.  Nutrimetabolomics: integrating metabolomics in nutrition to disentangle intake of animal-based foods.

Authors:  Hanne Christine Bertram; Louise Margrethe Arildsen Jakobsen
Journal:  Metabolomics       Date:  2018-02-14       Impact factor: 4.290

2.  Intake of hydrolyzed casein is associated with reduced body fat accretion and enhanced phase II metabolism in obesity prone C57BL/6J mice.

Authors:  Morten Rahr Clausen; Xumin Zhang; Christian C Yde; Ditte B Ditlev; Haldis H Lillefosse; Lise Madsen; Karsten Kristiansen; Bjørn Liaset; Hanne C Bertram
Journal:  PLoS One       Date:  2015-03-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.